Pediatric OSA—Spectrum of the Disease and Opportunities for Personalized Interventions
Journal of Personalized Medicine · 12.05.2026 · 16 (5) · 259
DOI: 10.3390/jpm16050259 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 12.05.2026. Verfasst von Hui-Leng Tan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Respiratory Medicine, Royal Brompton Hospital, London SW3 6NP, UK. Die Arbeit nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Heart Lung and Blood Institute, NIH.
Abstract (Originalsprache)
Pediatric obstructive sleep-disordered breathing encompasses a wide spectrum of diagnostic clusters, including primary snoring, upper airway resistance syndrome, mild, moderate, and severe obstructive sleep apnea, and obstructive hypoventilation. Even within these classifications, the symptomatic presentation involves a large array of variations, reflecting a wide phenotypic spectrum. Here, we aim to summarize current diagnostic criteria and explore the spectrum of disease, particularly highlighting the phenotypic variation and its potential relevance to therapeutic decisions and overall outcomes. It has become apparent that polysomnographic (PSG) indices do not correlate well with associated morbidities, even though one-night in-lab PSGs are considered the diagnostic gold standard. Novel approaches, including exploration of plasma and urine biomarkers and data-mining the physiological information embedded within the PSG, may enable the extraction of phenotypic information that can then be interpreted in conjunction with clinical data, including history, physical examination findings, risk factors, and associated disease morbidity, so that an individualized treatment plan can be optimally delineated.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Respiratory Medicine, Royal Brompton Hospital, London SW3 6NP, UK.
- Division of Pediatric Pulmonology, Pediatric Sleep Center, Department of Child Health, University of Missouri School of Medicine and MUHC Children's Hospital, Columbia, MO 65201, USA.
- Departments of Pediatrics and Biomedical Sciences, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25755, USA.
ORCID-Profile: Athanasios Kaditis, David Gozal
Förderung
- National Heart Lung and Blood Institute
- NIH
Zitieren
APA
Tan, H. L., Kaditis, A., & Gozal, D. (2026). Pediatric OSA—Spectrum of the Disease and Opportunities for Personalized Interventions. Journal of Personalized Medicine, 16(5), 259. https://doi.org/10.3390/jpm16050259
Vancouver
Tan HL, Kaditis A, Gozal D. Pediatric OSA—Spectrum of the Disease and Opportunities for Personalized Interventions. Journal of Personalized Medicine. 2026;16(5):259. doi:10.3390/jpm16050259
BibTeX
@article{Tan2026,
author = {Tan, Hui-Leng and Kaditis, Athanasios and Gozal, David},
title = {Pediatric OSA—Spectrum of the Disease and Opportunities for Personalized Interventions},
journal = {Journal of Personalized Medicine},
year = {2026},
volume = {16},
number = {5},
pages = {259},
doi = {10.3390/jpm16050259}
}
EUVIMED